Chang JW - Search Results

1

Comparison of genomic signatures of non-small cell lung cancer recurrence between two microarray platforms.

Chang JW, Wei NC, Su HJ, Huang JL, Chen TC, Wu YC, Yu CT, Hou MM, Hsieh CH, Hsieh JJ, Wu CE, Cheng HY, Hsu T, Wang TH. Chang JW, et al. Anticancer Res. 2012 Apr;32(4):1259-65. Anticancer Res. 2012. PMID: 22493357

2

Phase II study of regimen of gemcitabine and cisplatin in advanced non-small cell lung cancer.

Chen SC, Lin MC, Chang JW, Wang SW, Lee CH, Tsao TC. Chen SC, et al. Among authors: chang jw. Jpn J Clin Oncol. 2000 Nov;30(11):494-8. doi: 10.1093/jjco/hyd123. Jpn J Clin Oncol. 2000. PMID: 11155919 Clinical Trial.

3

Predictors for patterns of brain relapse and overall survival in patients with non-small cell lung cancer.

Tang SG, Tseng CK, Tsay PK, Chen CH, Chang JW, Pai PC, Hong JH. Tang SG, et al. Among authors: chang jw. J Neurooncol. 2005 Jun;73(2):153-61. doi: 10.1007/s11060-004-3725-4. J Neurooncol. 2005. PMID: 15981106 Clinical Trial.

4

Different responses to gefitinib in lung adenocarcinoma coexpressing mutant- and wild-type epidermal growth factor receptor genes.

Chou WC, Huang SF, Yeh KY, Wang HM, Liu MY, Hsieh JJ, Cheung YC, Chang JW. Chou WC, et al. Among authors: chang jw. Jpn J Clin Oncol. 2006 Aug;36(8):523-6. doi: 10.1093/jjco/hyl057. Epub 2006 Jun 27. Jpn J Clin Oncol. 2006. PMID: 16803841

5

Clodronate alleviates cachexia and prolongs survival in nude mice xenografted with an anaplastic thyroid carcinoma cell line.

Wang CH, Shen YC, Hsieh JJ, Yeh KY, Chang JW. Wang CH, et al. Among authors: chang jw. J Endocrinol. 2006 Aug;190(2):415-23. doi: 10.1677/joe.1.06490. J Endocrinol. 2006. PMID: 16899574

6

Erlotinib response of EGFR-mutant gefitinib-resistant non-small-cell lung cancer.

Chang JW, Chou CL, Huang SF, Wang HM, Hsieh JJ, Hsu T, Cheung YC. Chang JW, et al. Lung Cancer. 2007 Dec;58(3):414-7. doi: 10.1016/j.lungcan.2007.05.018. Epub 2007 Jul 6. Lung Cancer. 2007. PMID: 17618013

7

Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: a chromogenic in situ hybridization study of 182 patients.

Chang JW, Liu HP, Hsieh MH, Fang YF, Hsieh MS, Hsieh JJ, Chiu YT, Tsai HY, Chen YH, Chen YT, Hsu HY, Chen YT, Tsai SF, Chen YR, Hsi BL, Huang SF. Chang JW, et al. Lung Cancer. 2008 Sep;61(3):328-39. doi: 10.1016/j.lungcan.2008.01.009. Epub 2008 Mar 4. Lung Cancer. 2008. PMID: 18304690

8

Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications.

Wu CC, Hsu HY, Liu HP, Chang JW, Chen YT, Hsieh WY, Hsieh JJ, Hsieh MS, Chen YR, Huang SF. Wu CC, et al. Among authors: chang jw. Cancer. 2008 Dec 1;113(11):3199-208. doi: 10.1002/cncr.23925. Cancer. 2008. PMID: 18932251 Free article.

9

Bisphosphonate zoledronic acid enhances the inhibitory effects of gefitinib on EGFR-mutated non-small cell lung carcinoma cells.

Chang JW, Hsieh JJ, Shen YC, Yeh KY, Wang CH, Li YY, Hsu T. Chang JW, et al. Cancer Lett. 2009 Jun 8;278(1):17-26. doi: 10.1016/j.canlet.2008.12.019. Epub 2009 Feb 23. Cancer Lett. 2009. PMID: 19233551

10

A randomized study of gemcitabine plus cisplatin and vinorelbine plus cisplatin in patients with advanced non-small-cell lung cancer.

Chang JW, Tsao TC, Yang CT, Lin MC, Cheung YC, Liaw CC, Chen CH. Chang JW, et al. Chang Gung Med J. 2008 Nov-Dec;31(6):559-66. Chang Gung Med J. 2008. PMID: 19241895 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,162 results

Search Page

Filters